Suppr超能文献

黄茶多糖通过调节肠道微生物群和胆汁酸代谢来预防小鼠非酒精性脂肪肝病。

Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice.

机构信息

School of Life Sciences, Anhui University, Hefei, Anhui 230601, PR China; Department of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui 230012, PR China; Institute of Pharmaceutics, Anhui Academy of Chinese Medicine, Hefei, Anhui 230012, PR China; Key Laboratory for Ecological Engineering and Biotechnology of Anhui Province, Hefei 230601, PR China.

School of Life Sciences, Anhui University, Hefei, Anhui 230601, PR China; Key Laboratory for Ecological Engineering and Biotechnology of Anhui Province, Hefei 230601, PR China.

出版信息

Phytomedicine. 2024 Oct;133:155919. doi: 10.1016/j.phymed.2024.155919. Epub 2024 Aug 6.

Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is a major clinical and global public health issue, with no specific pharmacological treatment available. Currently, there is a lack of approved drugs for the clinical treatment of NAFLD. Large-leaf yellow tea polysaccharides (YTP) is a natural biomacromolecule with excellent prebiotic properties and significant therapeutic effects on multiple metabolic diseases. However, the specific mechanisms by which YTP regulates NAFLD remain unclear.

PURPOSE

This study aims to explore the prebiotic effects of YTP and the potential mechanisms by which it inhibits hepatic cholesterol accumulation in NAFLD mice.

METHODS

The effects of YTP on lipid accumulation were evaluated in NAFLD mice through obesity trait analysis and bile acids (BAs) metabolism assessment. Additionally, fecal microbiota transplantation (FMT) was performed, and high-throughput sequencing was employed to investigate the mechanisms underlying YTP's regulatory effects on gut microbiota and BA metabolism.

RESULTS

Our study demonstrated that YTP altered the constitution of colonic BA, particularly increasing the levels of conjugated BA and non-12OH BA, which suppressed ileum FXR receptors and hepatic BA reabsorption, facilitated BA synthesis, and fecal BA excretion. The modifications were characterized by a decrease in the levels of FXR, FGF15, FGFR4, and ASBT proteins, and an increase in the levels of Cyp7a1 and Cyp27a1 proteins. YTP might affect enterohepatic circulation and by the activated the hepatic FXR-SHP pathway. Meanwhile, YTP reshaped the intestinal microbiome structure by decreasing BSH-producing genera and increasing taurine metabolism genera. The correlation analysis implied that Muribaculaceae, Pseudomonas, acterium_coprostanoligenes_group, Clostridiales, Lachnospiraceae_NK4A136_group, Delftia, Dubosiella, and Romboutsia were strongly correlated with specific BA monomers.

CONCLUSIONS

YTP modulates bile salt hydrolase-related microbial genera to activate alternative bile acid synthesis pathways, thereby inhibiting NAFLD progression. These results suggest that YTP may serve as a potential probiotic formulation, offering a feasible dietary intervention for NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是一个主要的临床和全球公共卫生问题,目前尚无特定的药物治疗方法。目前,尚无批准用于治疗 NAFLD 的临床药物。大叶黄茶多糖(YTP)是一种具有优异益生元特性的天然生物大分子,对多种代谢性疾病具有显著的治疗作用。然而,YTP 调节 NAFLD 的具体机制尚不清楚。

目的

本研究旨在探讨 YTP 的益生元作用及其在 NAFLD 小鼠中抑制肝胆固醇积累的潜在机制。

方法

通过肥胖特征分析和胆汁酸(BA)代谢评估,评估 YTP 对 NAFLD 小鼠脂质积累的影响。此外,进行粪便微生物群移植(FMT),并采用高通量测序研究 YTP 调节肠道微生物群和 BA 代谢的机制。

结果

我们的研究表明,YTP 改变了结肠 BA 的构成,特别是增加了共轭 BA 和非 12OH BA 的水平,抑制了回肠 FXR 受体和肝 BA 重吸收,促进了 BA 合成和粪便 BA 排泄。这些变化的特征是 FXR、FGF15、FGFR4 和 ASBT 蛋白水平降低,Cyp7a1 和 Cyp27a1 蛋白水平升高。YTP 可能通过激活肝 FXR-SHP 途径影响肠肝循环。同时,YTP 通过减少产生 BSH 的属和增加牛磺酸代谢属来重塑肠道微生物组结构。相关性分析表明,Muribaculaceae、Pseudomonas、acterium_coprostanoligenes_group、Clostridiales、Lachnospiraceae_NK4A136_group、Delftia、Dubosiella 和 Romboutsia 与特定的 BA 单体强烈相关。

结论

YTP 调节胆盐水解酶相关微生物属以激活替代胆汁酸合成途径,从而抑制 NAFLD 进展。这些结果表明,YTP 可能作为一种潜在的益生菌制剂,为 NAFLD 提供可行的饮食干预。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验